Post-market study of CorSky implantable defibrillators for fast heart rhythms or heart failure
Checks safety of CorSky defibrillators in adults with fast heart rhythms or heart failure.
Plain-language title generated from the registry record
Registry title: BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs
Key facts
- Where
- Gera and Würzburg, GermanySee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Source: NCT07360158, who can take part
Where in Germany
- SRH Wald-Klinikum Gera GmbHGera, GermanyTaking people
- Universitätsklinikum WürzburgWürzburg, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Biotronik SE & Co. KG
- Trial code
- NCT07360158
- Record updated
- 10 July 2026
- Original description
The CorSky family is BIOTRONIK´s new generation of ICDs. They are the successor devices of the current Acticor/Rivacor family and inherit all iShock/iShock_BC (Ilivia Neo, Intica Neo) implant and programmer software features.Read full original descriptionShow less
Post-market Study for the CorSky Family of ICDs
The CorSky family is BIOTRONIK´s new generation of ICDs. They are the successor devices of the current Acticor/Rivacor family and inherit all iShock/iShock_BC (Ilivia Neo, Intica Neo) implant and programmer software features.
The new features of CorSky Family are either true novel BIOTRONIK ICD features or mainly driven by unification with the Amvia pacemaker family (Amvia Edge, -Sky).
The goal of the study is to confirm the safety and performance of the CorSky Family of ICDs and CRT-Ds.
Inclusion: Standard indication for ICD or CRT-D therapy according to clinical guidelines; Planned for de novo implantation of an ICD/CRT-D, or upgrade/exchange from existing ICD/CRT-D or pacemaker; Ability to understand the nature of the study; Ability and willingness to perform all on-site follow-up visits at the study site; Ability and willingness to use the CardioMessenger and acceptance of the BIOTRONIK Home Monitoring® concept.
Exclusion: Planned cardiac surgical procedures or interventional measures other than the study procedure within the next 12 months; Age less than 18 years; For VR-T DX and CRT-DX: Permanent atrial tachyarrhythmia; For VR-T DX and CRT-DX: Patients requiring atrial pacing; Planned for His-Bundle-Pacing; Pregnant or breast feeding; Participation in an interventional clinical investigation in parallel to this study. ,; Life-expectancy less than 12 months.